title: Comment on: Schmidt MI, Duncan BB, Vigo A et al (2006) Leptin and incident type 2 diabetes: risk or protection? Diabetologia 49:2086-2096.
authors.forename: M B
authors.initials: MB
authors.lastname: Snijder
authors.forename: J M
authors.initials: JM
authors.lastname: Dekker
authors.forename: L M
authors.initials: LM
authors.lastname: Bouter
authors.forename: R J
authors.initials: RJ
authors.lastname: Heine
authors.forename: C D A
authors.initials: CD
authors.lastname: Stehouwer
authors.forename: J C
authors.initials: JC
authors.lastname: Seidell
mesh_terms: D000368:Aged; D003924:Diabetes Mellitus, Type 2 / Q000453:epidemiology* / Q000503:physiopathology / Q000517:prevention & control*; D005260:Female; D006801:Humans; D007333:Insulin Resistance / Q000502:physiology; D020738:Leptin / Q000502:physiology*; D008297:Male; D008875:Middle Aged; D009765:Obesity / Q000503:physiopathology; D012307:Risk Factors; D012727:Sex Characteristics
chemical_list: D020738:Leptin